Abetimus
Jump to navigation
Jump to search
Clinical data | |
---|---|
Trade names | Riquent |
ATC code | |
Identifiers | |
CAS Number | |
PubChem SID | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C1632H1944N610Na156O970P156S4 |
Molar mass | 54171.35 g·mol−1 |
(what is this?) (verify) |
Abetimus (trade name Riquent) is an immunosuppressant.[1] It is a synthetic biological called a tolerogen. It is made of four double-stranded oligodeoxyribonucleotides that are attached to a carrier platform and are designed to block specific B-cell anti double stranded DNA antibodies.[2] It may also complex anti dsDNA antibodies together, therefore disabling them. This way abetimus was supposed to help treat systemic lupus erythematosus and specifically lupus nephritis.
It was developed by La Jolla Pharmaceutical, who applied for marketing authorisations in the mid-2000s, but the drug was never marketed in the US or in Europe.[3][4]
References
- ^ "Abetimus: Abetimus sodium, LJP 394". BioDrugs. 17 (3). Springer Nature Switzerland AG: 212–5. 2003. doi:10.2165/00063030-200317030-00009. PMID 12749759. S2CID 19896886.
- ^ Wallace DJ (January 2001). "Clinical and pharmacological experience with LJP-394". Expert Opinion on Investigational Drugs. 10 (1). Informa: 111–7. doi:10.1517/13543784.10.1.111. PMID 11116284. S2CID 43518002.
- ^ "Riquent Approval Status". Drugs.com. Retrieved 7 January 2017.
- ^ "Riquent". European Medicines Agency. Retrieved 7 January 2017.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles with changed KEGG identifier
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Immunosuppressants
- All stub articles
- Antineoplastic and immunomodulating drug stubs